SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Erin K. J. Spengler, Jeffrey Dunkelberg, Ron Schey, Alcoholic Hepatitis: Current Management, Digestive Diseases and Sciences, 2014,

    CrossRef

  2. 2
    Rajiv Jalan, Javier Fernandez, Reiner Wiest, Bernd Schnabl, Richard Moreau, Paolo Angeli, Vanessa Stadlbauer, Thierry Gustot, Mauro Bernardi, Rafael Canton, Agustin Albillos, Frank Lammert, Alexander Wilmer, Rajeshwar Mookerjee, Jordi Vila, Rita Garcia-Martinez, Julia Wendon, José Such, Juan Cordoba, Arun Sanyal, Guadalupe Garcia-Tsao, Vicente Arroyo, Andrew Burroughs, Pere Ginès, Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013, Journal of Hepatology, 2014, 60, 6, 1310

    CrossRef

  3. 3
    Bernd Schnabl, David A. Brenner, Interactions Between the Intestinal Microbiome and Liver Diseases, Gastroenterology, 2014, 146, 6, 1513

    CrossRef

  4. 4
    Marius Trøseid, Ingjerd W. Manner, Karin K. Pedersen, Judith M. Haissman, Dag Kvale, Susanne D. Nielsen, Microbial Translocation and Cardiometabolic Risk Factors in HIV Infection, AIDS Research and Human Retroviruses, 2014, 30, 6, 514

    CrossRef

  5. 5
    Dominic R. Aldridge, Edward J. Tranah, Debbie L. Shawcross, Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation, Journal of Clinical and Experimental Hepatology, 2014,

    CrossRef

  6. 6
    Jonathan P Sturgeon, Debbie L Shawcross, Recent insights into the pathogenesis of hepatic encephalopathy and treatments, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 83

    CrossRef

  7. 7
    Bhaswati Sinha, Muni Rubens, Systemic immune activation in HIV and potential therapeutic options, Immunopharmacology and Immunotoxicology, 2014, 36, 2, 89

    CrossRef

  8. 8
    Nisheet Waghray, Abhijeet Waghray, Kevin Mullen, Treatment Options for Covert Hepatic Encephalopathy, Current Treatment Options in Gastroenterology, 2014, 12, 2, 229

    CrossRef

  9. 9
    Bernd Schnabl, Linking intestinal homeostasis and liver disease, Current Opinion in Gastroenterology, 2013, 29, 3, 264

    CrossRef

  10. 10
    Pablo Bellot, Rubén Francés, Jose Such, Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications, Liver International, 2013, 33, 1
  11. 11
    Peter Huebener, Robert F. Schwabe, Regulation of wound healing and organ fibrosis by toll-like receptors, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 7, 1005

    CrossRef

  12. 12
    Beverley Kok, Matthew R. Foxton, Christopher Clough, Debbie L. Shawcross, Rifaximin is an efficacious treatment for the parkinsonian phenotype of hepatic encephalopathy, Hepatology, 2013, 58, 4
  13. 13
    Bjørn S. Madsen, Troels Havelund, Aleksander Krag, Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers, Advances in Therapy, 2013, 30, 7, 659

    CrossRef

  14. 14
    Babafemi Taiwo, Luis Barcena, Randall Tressler, Understanding and Controlling Chronic Immune Activation in the HIV-Infected Patients Suppressed on Combination Antiretroviral Therapy, Current HIV/AIDS Reports, 2013, 10, 1, 21

    CrossRef

  15. 15
    J. Cheng, K. W. Krausz, N. Tanaka, F. J. Gonzalez, Chronic Exposure to Rifaximin Causes Hepatic Steatosis in Pregnane X Receptor-Humanized Mice, Toxicological Sciences, 2012, 129, 2, 456

    CrossRef

  16. 16
    Daniel Benten, Reiner Wiest, Gut microbiome and intestinal barrier failure – The “Achilles heel” in hepatology?, Journal of Hepatology, 2012, 56, 6, 1221

    CrossRef

  17. 17
    Vandana Khungar, Fred Poordad, Hepatic Encephalopathy, Clinics in Liver Disease, 2012, 16, 2, 301

    CrossRef

  18. 18
    Netanya G. Sandler, Daniel C. Douek, Microbial translocation in HIV infection: causes, consequences and treatment opportunities, Nature Reviews Microbiology, 2012, 10, 9, 655

    CrossRef

  19. 19
    Ming Luo, Lei Li, Er-Na Yang, Wu-Kui Cao, Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis, Hepatology Research, 2012, 42, 12